<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04064489</url>
  </required_header>
  <id_info>
    <org_study_id>49RC19_0027</org_study_id>
    <nct_id>NCT04064489</nct_id>
  </id_info>
  <brief_title>Thromboembolic Risk Stratification by TRiP(Cast) Score to Guide Physicians in Preventive Treatment Prescriptions for Patients With Lower Limb Trauma Requiring Brace or castING.</brief_title>
  <acronym>CASTING</acronym>
  <official_title>Thromboembolic Risk Stratification by TRIP Score (Cast) to Guide Physicians in Preventive Treatment Prescriptions for Patients With Lower Limb Trauma Requiring Brace or Casting.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Angers</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Angers</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Non-surgical traumas to the lower limbs that require orthopedic immobilisation (plaster or
      splint) are a frequent reason for going to accident and emergency. Due to venous stasis
      caused by immobilisation, hypercoagulable states and vascular injuries brought on by the
      trauma, these patients are at risk of developing VTE. For this reason, it is current practice
      in France and Belgium for the majority of patients to receive a preventative anticoagulant
      treatment. However, the benefit of this treatment, which has a considerable cost, is
      controversial. Contrary to French recommendations, American recommendations from 2012
      actually advise against systematic preventative medicine, with prevention appearing to be
      effective primarily in studies with restrictive inclusion criteria. The most significant
      randomised controlled study on the subject did not show the benefit of low-molecular-weight
      heparin (LMWH) on the rate of symptomatic VTE among 1,435 non-selected patients. Therefore,
      in 2017, the Cochrane meta-analysis concluded that stratification of the risk of
      thromboembolism is required.

      For this purpose, in collaboration with the Dutch team of Nemeth et al. we have recently
      developed a risk stratification model that takes into consideration the patient's
      characteristics, the type of immobilisation and the severity of the trauma: the TRiP(cast)
      score. This score is applied retrospectively to a large cohort and demonstrates excellent
      prognostic performances (AUC (area under the curve) of 0.74). In addition, when using a &lt;7
      limits, it makes it possible to identify a large group of patients at very low risk of
      developing VTE (negative predictive value: 99.2%).

      The aim of the CASTING study is to prospectively demonstrate the reliability and utility of
      the TRiP(cast) score by showing that patients with orthopaedic immobilisation of a lower limb
      who are not receiving preventative treatment on the basis of a TRiP(cast) score of &lt;7 have a
      very low rate of symptomatic VTE, which allows for a significant reduction in prescriptions
      of anticoagulants in comparison with prior practices.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 16, 2020</start_date>
  <completion_date type="Anticipated">January 2022</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of symptomatic venous thromboembolic events (deep vein thrombosis and / or pulmonary embolism)</measure>
    <time_frame>Day 90</time_frame>
    <description>To demonstrate the reliability and safety of the decision not to implement thromboprophylaxis in patients with orthopedic immobilization for lower extremity trauma and Trip(cast) &lt; 7</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the rate of prescription for thromboprophylaxis</measure>
    <time_frame>Day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of symptomatic venous thromboembolic events (deep vein thrombosis and / or pulmonary embolism)</measure>
    <time_frame>Day 90</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The rate of complications of preventive anticoagulant treatment (bleeding)</measure>
    <time_frame>Day 90</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The direct cost of preventive anticoagulant treatment when the Trip(cast) score is applied compared to current practices</measure>
    <time_frame>Day 90</time_frame>
    <description>treatment, nurse, blood test...cost of care</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physicians' satisfaction using likert's scale</measure>
    <time_frame>Day 1</time_frame>
    <description>5 level ladder : from totally unsatisfied to totally satisfied</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2100</enrollment>
  <condition>Lower Limb Trauma</condition>
  <arm_group>
    <arm_group_label>neutral</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No specific instructions for prescribing prophylaxis or not</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TRIPscore</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>calculation of the TRIPcast score and prescription of prophylactic or not according to the result (score &gt; or = 7 : treatment (low molecular weight heparin or fondaparinux); score &lt; 7 : no treatment)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>TRIPscore</intervention_name>
    <description>TRIPcast score calculation</description>
    <arm_group_label>TRIPscore</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Consultation in one of the emergency department participating in the study,

          -  Isolated trauma from lower limb,

          -  Rigid (plaster or resin) or semi-rigid immobilization for an assumed duration of at
             least 7 days,

          -  Adults (18 years),

          -  Affiliated patient or beneficiary of a social security,

          -  Patient with prior informed consent.

        Exclusion Criteria:

          -  Patient with anticoagulant treatment at the time of trauma,

          -  Trauma requiring hospitalization of more than 48 hours,

          -  Co-morbidity(s) requiring hospitalization of more than 48 hours at the time of
             inclusion,

          -  Any factor making 90-day follow-up impossible,

          -  Pregnant, nursing or childbearing patient,

          -  Patient deprived of liberty by judicial or administrative decision,

          -  Patient undergoing psychiatric care under duress,

          -  Patient subject to a legal protection measure,

          -  Patient unable to give free and informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Delphine Douillet, MD</last_name>
    <phone>0241356650</phone>
    <phone_ext>+33</phone_ext>
    <email>delphine.douillet@chu-angers.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clinique Universitaire Saint-Luc</name>
      <address>
        <city>Bruxelles</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andr√©a PENALOZA</last_name>
      <email>andrea.penaloza@uclouvain.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier d'Agen</name>
      <address>
        <city>Agen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Albert TRINH-DUC</last_name>
      <email>albert.trinh-duc@ch-agen-nerac.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Angers</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Delphine DOUILLET, MD</last_name>
      <email>delphine.douillet@chu-angers.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Cholet</name>
      <address>
        <city>Cholet</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Laure Baudin, MD</last_name>
      <email>laure.baudin@ch-cholet.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Grenoble</name>
      <address>
        <city>Grenoble</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maxime Maignan, MD</last_name>
      <email>mmaignan@chu-grenoble.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Le Mans</name>
      <address>
        <city>Le Mans</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thibault SCHOTTE</last_name>
      <email>tschotte@ch-lemans.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Nantes</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Emmanuel MONTASSIER</last_name>
      <email>emmanuel.montassier@chu-nantes.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier d'Orl√©ans</name>
      <address>
        <city>Orl√©ans</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anne MALET</last_name>
      <email>anne.malet@chr-orleans.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>APHP Bichat</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Enrique CASALINO</last_name>
      <email>enrique.casalino@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>APHP Cochin</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Florence DUMAS</last_name>
      <email>florence.dumas@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Poitiers</name>
      <address>
        <city>Poitiers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Olivier MIMOZ, MD, PhD</last_name>
      <email>olivier.mimoz@chu-poitiers.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Rennes</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Louis SOULAT</last_name>
      <email>louis.soulat@chu-rennes.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Saint-Brieuc</name>
      <address>
        <city>Saint-Brieuc</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Christian BRICE</last_name>
      <email>christian.brice@ch-stbrieuc.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Toulouse</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nathalie LECOULES</last_name>
      <email>lecoules.n@chu-toulouse.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Tours</name>
      <address>
        <city>Tours</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nathalie POLISSET</last_name>
      <email>n.polisset@chu-tours.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 19, 2019</study_first_submitted>
  <study_first_submitted_qc>August 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 22, 2019</study_first_posted>
  <last_update_submitted>June 18, 2020</last_update_submitted>
  <last_update_submitted_qc>June 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

